This pharma stock is set to surge 71% thanks to autoimmune disease treatment

Pelican Press · 2024-10-03T13:47:44+0000

This is the hidden content, please Sign In or Sign Up This pharma stock is set to surge 71% thanks to autoimmune ******** treatment Oppenheimer thinks a key treatment for a range of autoimmune ********* can be a growth catalyst for Dianthus Therapeutics stock. The firm initiated coverage of the clinical stage biotechnology company with an outperform rating and a $48 per share price target in a Wednesday note. Oppenheimer’s forecast implies more than 71% upside from Wednesday’s $27.98 close. Shares have soared more than 169% in 2024. DNTH YTD mountain Dianthus Therapeutics stock. Analyst Trevor Allred attributed his rating to the potential for the company’s monoclonal antibody DNTH103 to treat a range of rare autoimmune conditions that include generalized myasthenia gravis, multifocal motor neuropathy and chronic inflammatory demyelinating polyneuropathy. He estimates a more than $20 billion market for this treatment. “We see DNTH103 demonstrating potentially superior dosing/efficacy compared to on-market and late clinical-stage products in clinical trials, and anticipate data would support uptake in burgeoning markets across indications, led by the market expansion efforts of multiple pharma competitors,” Allred said. By 2035, the analyst said DNTH103 could tally $1 billion in sales when used to treat multifocal motor neuropathy, $2 billion for chronic inflammatory demyelinating polyneuropathy and $2.5 billion for generalized myasthenia gravis. Investors will be able to gain insight into the treatment’s effectiveness in clinical data that will begin to be released in mid-2025, Allred said. This is the hidden content, please Sign In or Sign Up #pharma #stock #set #surge #autoimmune #******** #treatment This is the hidden content, please Sign In or Sign Up This is the hidden content, please Sign In or Sign Up

By Pelican Press,
October 3, 2024 in World News

https://hopzone.eu/forums/topic/141308-this-pharma-stock-is-set-to-surge-71-thanks-to-autoimmune-disease-treatment/

Followers 1

Trader Feedback

0 0 0

Total Rating 0%

Diamond Member

- Share

Posted October 3, 2024

This is the hidden content, please

This pharma stock is set to surge 71% thanks to autoimmune ******** treatment

This is the hidden content, please

#pharma #stock #set #surge #autoimmune #******** #treatment

This is the hidden content, please

Link to comment

https://hopzone.eu/forums/topic/141308-this-pharma-stock-is-set-to-surge-71-thanks-to-autoimmune-disease-treatment/

Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign in

Already have an account? Sign in here.

https://hopzone.eu/forums/topic/141308-this-pharma-stock-is-set-to-surge-71-thanks-to-autoimmune-disease-treatment/

Followers 1

Go to topic listing

Most Contributions
1. Pelican Press
  142347
2. Steam
  47661
3. Editor
  12042
4. Kotaku
  3906
5. SpaceMan
  1899

Vote for the server

To vote for this server you must login.

Sign In

or

Sign Up
Recently Browsing 0 members
- No registered users viewing this page.

Sign In

Home

Activity

Store

All Servers

This pharma stock is set to surge 71% thanks to autoimmune disease treatment

Recommended Posts

Pelican Press 0

Trader Feedback

This pharma stock is set to surge 71% thanks to autoimmune ******** treatment

Link to comment

Share on other sites

Create an account or sign in to comment

Create an account

Sign in

Most Contributions

Vote for the server

Recently Browsing 0 members

Important Information